Top trending penny stocks today: Check out the details

Be the First to Comment Read

Top trending penny stocks today: Check out the details

 Top trending penny stocks today: Check out the details
Image source: Mats,Shutterstock

Summary

  • Eyegate Pharmaceuticals, Inc (Nasdaq: EYEG) incurred losses of US$2.58 million in Q1, 2021.
  • ObsEva SA (Nasdaq: OBSV) has a market capitalization of US$229 million.
  • Dyadic International, Inc (Nasdaq: DYAI) earned revenue of US$460000 in Q1, 2021.

Prices of many penny stocks have soared in recent times due to various developments. For example, the stock of Oragenics Inc. (Amex: OGEN) surged by over 43 percent as it signed an agreement with the Canadian government to develop a next generation Covid-19 vaccine.

Here we look at five penny stocks that saw gains on July 27.


 

Source: Pixabay.

Eyegate Pharmaceuticals, Inc. (Nasdaq: EYEG)

Eyegate Pharmaceuticals, Inc is a clinical-stage pharmaceutical company that develops and sells medication for eye diseases. The company on July 26 announced the appointment of Dr Brian M Strem as the chief executive officer.

The stock of the EYEG traded at US44.42 at 11.27 am ET on July 27. The stock value of the American company fell by 5.73 percent YTD. The market capitalization of EYEG is US$32 million.

The forward P/E one year is -2.05, and the earnings per share are US$-1.71. The beta is 1.11. The 52 weeks highest and lowest stock price of EYEG is US$8.18 and US$3.20. And the share volume is 34,302,134.

The company incurred losses of US$2.58 million in Q1, 2021. And its losses for Q1, 2020 were US$1.97 million.

Also read: Top penny stocks to consider before prices skyrocket

ObsEva SA (Nasdaq: OBSV)

ObsEva SA develops oral drugs for the reproductive systems of women from birth to contraceptives. OBSV and Organon (NYSE: OGN) have agreed to develop a treatment for preterm labour for pregnant women, as per OBSV’s press note released on July 26.

The stock of the Switzerland-based company traded at US$2.98 at 11.37 am ET, an increase of 17.86 percent over the closing price on July 26. The stock value of this medical research company went up by 46.07 percent YTD.

The market capitalization of the OBSV is US$229 million. Its P/E forward one year and EPS are -2.50 and US$-1.48, respectively.

The pharmaceutical company recorded total revenue of US$10000 in Q1, 2021. The operating losses for this period were US$11.70 million and net losses of US$26.60 million.

Dyadic International, Inc (Nasdaq: DYAI)

Dyadic International, Inc develops methods to produce enzymes and proteins for commercial use.

The stock of the global company traded at US$4.11 at 11.46 am ET on July 27, a rise of 19.19 percent over the closing price of July 26. The market capitalization of this US-based biotechnology company is US$114 million.

Its forward P/E one year is -8.6, and EPS is US$-.034. The beta is -0.02.

The company earned revenue of US$460000 in Q1, 2021 and US$320000 in q1, 2020. The gross profit for Q1, 2021 was US$70000 and for Q1, 2020 US$40000.

Exela Technologies, Inc. (Nasdaq: XELA)

Exela Technologies, Inc is a business process automation company. It provides solutions to information technology, healthcare, legal, and public sectors. Company on July 27 revealed that its products DMR and DrySign received tremendous response from users in Q2.

The stock of XELA traded at US$2.765 at 11.59 am ET on July 27, a rise of 12.02 percent over the closing price of July 26. The Stock of American companies increased by 124.33 percent YTD. The market capitalization of XELA is US$165 million.

The forward P/E one year is -1.41, and the beta is 1.81. The 52 weeks lowest and highest stock prices are US$0.99 and US$7.82. The share volume is 95,936,571.

The total revenue of ZELA for Q1 of this year was US$300, and that is lower than US$365 million of Q1, 2020. The Gross profit for Q1, 2021 and 2020 were US$67.5 million and US$72.9 million. Operating income for this quarter is US$4.3 million, and net losses were US$39.2 million.

Also read: Six hot penny stocks to explore when Delta fear settles down

Oragenics Inc (Amex: OGEN)

Oragenics Inc is trying to produce immunization products to combat coronavirus.

The stock of OGEN traded at 0.9261 at 12.14 pm ET on July 27, up by 47.93 percent over the closing price of July 26. The market capitalization of the biopharmaceutical company is US$114 million.

Its forward P/E one year is -3.13, and the EPS is US$-0.42. The beta is 0.28. The lowest and highest stock price in the last 52 weeks is US$0.38 and US$1.80. The share volume is 173,795,596.

Please note: The above constitutes a preliminary view, and any interest in stocks/cryptocurrencies should be evaluated further from an investment point of view.

Disclaimer

Speak your Mind

Featured Articles